Searched for
ROCHE ASTRAZENECA
Pharma companies announce direct-to-consumer sales and price cuts in USSeveral drug makers are now selling medicines directly to Americans. This move follows President Trump's push to reduce prescription drug p...
US Pfizer deal powers European health stocks as Trump policy haze clearsEuropean healthcare stocks jumped on Wednesday, mirroring moves in the United States, propelled by a deal between Pfizer and President Dona...
US pharma stocks gain up to 5% on Trump's move to slash drug pricesPresident Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries, setting pric...
Sanofi to build $1 billion insulin production base in ChinaSanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 million people i...
AstraZeneca may not stay in vaccines, but CEO has no COVID regretsSoriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...
AstraZeneca on hunt for acquisitions, says CEO Pascal SoriotSoriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...
Sanofi trial failure ends development of breast cancer treatment amcenestrantA trial dubbed AMEERA-5, which was testing amcenestrant on women with newly-diagnosed advanced breast cancer, was stopped early because an ...
Drug cos against move to rationalise trade margins on patented productsThe representatives of Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational pharma companies and domest...
AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
AstraZeneca's Pascal Soriot: Know the man behind the Covid vaccineThe development of the vaccine with scientists at Oxford University -- and their decision to make it available at cost -- has made the Angl...
The CEO who capped a $37 billion recovery with AstraZeneca dealNakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.
Aurobindo Pharma gets USFDA nod to market ulcer drugThe company's approved abbreviated new drug application (ANDA) is a generic version of AstraZeneca Pharmaceuticals' Prilosec capsules, it a...
5 startups have a brilliant plan to tackle the multibillion-dollar fake drug scourgeCompanies have stepped in to help consumers authenticate the drugs themselves using mobile technology, including these start-ups.
Ranbaxy slips nearly 5% as US pulls approval for AstraZeneca and Roche drugsThe FDA has stripped Ranbaxy of tentative approval and six-month exclusivity for a copy of Roche Holding AG's antiviral Valcyte, a fresh bl...
Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
- Ranbaxy ties up with Yemen’s Pharma
To strengthen its presence in the Middle-East, Ranbaxy Laboratories has started operations in Yemen by tying up with a local firm, Pharma.
- Blogs provide window to pharmaceutical industry in India
Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...